BACKGROUND AND AIMS: Many patients who undergo bariatric surgery will experience weight regain and effective strategies are needed to help these patients. A dilated gastrojejunal anastomosis (GJA) has been associated with weight recidivism after Roux-en-Y gastric bypass surgery (RYGB). Endoscopic transoral outlet reduction (TORe) with a full thickness endoscopic suturing device (Overstitch, Apollo Endosurgery, Austin, TX) is a minimally invasive therapeutic option. The primary aim of this project was to examine the safety and long-term efficacy data from three bariatric surgery centers and to conduct a systematic review and meta-analysis of the existing literature. METHODS: Patients who underwent TORe with the Overstitch device from Jan 2013 to Nov 2016 at 3 participating bariatric surgery centers were included in the multicenter analysis. For the systematic review and meta-analysis, a comprehensive search of multiple English databases was conducted. Random effects model was used. RESULTS: 130 consecutive patients across three centers underwent TORe with an endolumenal suturing device. These patients (mean age 47; mean BMI 36.8) had experienced 24.6% weight regain from nadir weight after RYGB. Average weight lost at 6, 12, and 18 months after TORe was 9.31 ± 6.7 kg (N = 84), 7.75 ± 8.4 kg (N = 70), 8 ± 8.8 kg (N = 46) (p < 0.01 for all three time points), respectively. The meta-analysis included 330 patients. The pooled weight lost at 12 months was 8.4 kg (95% CI 6.5-10.3) with no significant heterogeneity across included studies (p = 0.07). Overall, 14% of patients experienced nausea, 18% had pain and 8% required a repeat EGD. No serious adverse events reported. CONCLUSION: When implemented as part of a multidisciplinary intervention, TORe using endolumenal suturing is safe, reproducible, and effective approach to manage weight recidivism after RYGB and should be utilized early in the management algorithm of these patients.
BACKGROUND AND AIMS: Many patients who undergo bariatric surgery will experience weight regain and effective strategies are needed to help these patients. A dilated gastrojejunal anastomosis (GJA) has been associated with weight recidivism after Roux-en-Y gastric bypass surgery (RYGB). Endoscopic transoral outlet reduction (TORe) with a full thickness endoscopic suturing device (Overstitch, Apollo Endosurgery, Austin, TX) is a minimally invasive therapeutic option. The primary aim of this project was to examine the safety and long-term efficacy data from three bariatric surgery centers and to conduct a systematic review and meta-analysis of the existing literature. METHODS: Patients who underwent TORe with the Overstitch device from Jan 2013 to Nov 2016 at 3 participating bariatric surgery centers were included in the multicenter analysis. For the systematic review and meta-analysis, a comprehensive search of multiple English databases was conducted. Random effects model was used. RESULTS: 130 consecutive patients across three centers underwent TORe with an endolumenal suturing device. These patients (mean age 47; mean BMI 36.8) had experienced 24.6% weight regain from nadir weight after RYGB. Average weight lost at 6, 12, and 18 months after TORe was 9.31 ± 6.7 kg (N = 84), 7.75 ± 8.4 kg (N = 70), 8 ± 8.8 kg (N = 46) (p < 0.01 for all three time points), respectively. The meta-analysis included 330 patients. The pooled weight lost at 12 months was 8.4 kg (95% CI 6.5-10.3) with no significant heterogeneity across included studies (p = 0.07). Overall, 14% of patients experienced nausea, 18% had pain and 8% required a repeat EGD. No serious adverse events reported. CONCLUSION: When implemented as part of a multidisciplinary intervention, TORe using endolumenal suturing is safe, reproducible, and effective approach to manage weight recidivism after RYGB and should be utilized early in the management algorithm of these patients.
Authors: Lava Y Patel; Brittany Lapin; Craig S Brown; Thomas Stringer; Matthew E Gitelis; John G Linn; Woody E Denham; Elizabeth Farwell; Stephen Haggerty; Michael B Ujiki Journal: Surg Endosc Date: 2016-10-17 Impact factor: 4.584
Authors: Christopher C Thompson; Bipan Chand; Yang K Chen; Daniel C DeMarco; Larry Miller; Michael Schweitzer; Richard I Rothstein; David B Lautz; James Slattery; Michele B Ryan; Stacy Brethauer; Phillip Schauer; Mack C Mitchell; Anthony Starpoli; Gregory B Haber; Marc F Catalano; Steven Edmundowicz; Annette M Fagnant; Lee M Kaplan; Mitchell S Roslin Journal: Gastroenterology Date: 2013-04-05 Impact factor: 22.682
Authors: Maria Paula Carlini Cambi; Giorgio A P Baretta; Maurício Spagnol; Roberto Zilio; Carina Rossoni Journal: Obes Surg Date: 2019-03 Impact factor: 4.129
Authors: Zachary M Callahan; Bailey Su; Kristine Kuchta; Eliza Conaty; Stephanie Novak; John Linn; Faris M Murad; JoAnn Carbray; Michael Ujiki Journal: J Gastrointest Surg Date: 2019-12-10 Impact factor: 3.452
Authors: Saketh R Velapati; Meera Shah; Aravind R Kuchkuntla; Barham Abu-Dayyeh; Karen Grothe; Ryan T Hurt; Manpreet S Mundi Journal: Curr Nutr Rep Date: 2018-12
Authors: Guillermo Borjas; Nestor Sánchez; Ali Urdaneta; Andres Maldonado; Eduardo Ramos; Edward Fumero; Jose DiGiorgio Journal: J Surg Case Rep Date: 2022-05-14
Authors: Sérgio Barrichello; Manoel Dos Passos Galvão Neto; Thiago Ferreira de Souza; Eduardo Guimarães Hourmeaux de Moura; Maurício Minata; Ana Paula Oliveira de Quadros; Jaques Waisberg; Eduardo Grecco; Guilherme Macedo; Marco Silva; Luiz Gustavo de Quadros Journal: GE Port J Gastroenterol Date: 2018-02-08